Created at	Source	Raw Value	Validated value
July 20, 2022, noon	usa	Efficacy at Phase III Study;Immunogenicity at Phase II Study;Safety at Phase II and Phase III	Efficacy at Phase III Study;Immunogenicity at Phase II Study;Safety at Phase II and Phase III